Aciclovir topical patch - LabtecAlternative Names: Acyclovir topical patch - Labtec; LabiPatch
Latest Information Update: 20 Apr 2011
At a glance
- Originator Labtec
- Developer tesa Labtec
- Class Antivirals; Hypoxanthines; Small molecules
- Mechanism of Action DNA-directed DNA polymerase inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Phase I Herpesvirus infections